At a glance
- Originator Shionogi
- Class Antiallergics
- Mechanism of Action Prostaglandin D2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 01 Nov 2006 Discontinued - Phase-I for Asthma in Japan (PO)
- 01 Nov 2006 Discontinued - Phase-II for Asthma in Europe (PO)
- 01 Nov 2006 Discontinued - Phase-II for Asthma in USA (PO)